Magnetic mesoporous silica nanoparticles end-capped with hydroxyapatite for pH-responsive drug release

2013 ◽  
Vol 1 (37) ◽  
pp. 4828 ◽  
Author(s):  
Chun-Xia Zhao ◽  
Lei Yu ◽  
Anton P. J. Middelberg
RSC Advances ◽  
2015 ◽  
Vol 5 (29) ◽  
pp. 22365-22372 ◽  
Author(s):  
Yufang Zhu ◽  
Cuilian Tao

DNA-capped Fe3O4/SiO2 magnetic mesoporous silica (MMS) nanoparticles were developed for potential temperature controlled drug release and magnetic hyperthermia.


2016 ◽  
Vol 7 (7) ◽  
pp. 1475-1485 ◽  
Author(s):  
Panayiotis Bilalis ◽  
Leto-A. Tziveleka ◽  
Spyridon Varlas ◽  
Hermis Iatrou

Mesoporous silica nanoparticles (MSNs) bearing poly(l-histidine)-grafted nanogates were prepared by surface-initiated ROP. The obtained polypeptide-functionalized MSNs were used as smart pH-responsive nanocarriers for controlled drug release applications.


2020 ◽  
Vol 5 (6) ◽  
pp. 986-998
Author(s):  
Chao Chen ◽  
Tonghao Ma ◽  
Wen Tang ◽  
Xiaoli Wang ◽  
Yibing Wang ◽  
...  

This article introduced a reversibly pH-responsive and targeting nanocarrier based on mesoporous silica nanoparticles which could be utilized to reduce the “secondary” side effects on normal tissues.


RSC Advances ◽  
2015 ◽  
Vol 5 (121) ◽  
pp. 99875-99883 ◽  
Author(s):  
Yi Xu ◽  
Yufang Zhu ◽  
Stefan Kaskel

A smart therapeutic platform with potential controllable drug release and magnetic hyperthermia was constructed through the conjugation of carboxyl-modified DNA onto aminated magnetic mesoporous silica nanoparticles.


Sign in / Sign up

Export Citation Format

Share Document